We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

9 hedge funds and large institutions have $145K invested in Edesa Biotech in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% more ownership

Funds ownership: 0.05% → 0.07% (+0.02%)

0% more funds holding

Funds holding: 9 → 9 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

4% less capital invested

Capital invested by funds: $151K → $145K (-$6K)

Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$47.1K
2
Deutsche Bank
Deutsche Bank
Germany
+$44.7K
3
JP Morgan Chase
JP Morgan Chase
New York
+$495
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$283

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$29.7K
2
UBS Group
UBS Group
Switzerland
-$5.8K
3
AG
Advisor Group
Arizona
-$212
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$103K +$47.1K +1,332 +59%
Deutsche Bank
2
Deutsche Bank
Germany
$41K +$44.7K +1,264 +761%
AG
3
Advisor Group
Arizona
$1K -$212 -6 -25%
Morgan Stanley
4
Morgan Stanley
New York
– -$29.7K -838 Closed
UBS Group
5
UBS Group
Switzerland
– -$5.8K -164 -91%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
– +$283 +8 New
JP Morgan Chase
7
JP Morgan Chase
New York
– +$495 +14 New

EDSA Hedge Fund Activity: Q4 2019 in Review

9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2019, worth a combined $145K — down 4% from $151K a quarter earlier.

Fund positioning in EDSA was balanced in Q4 2019: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $47.1K. The largest seller was Morgan Stanley, exiting entirely with an estimated $29.7K sold.

  • 9 institutional investors held Edesa Biotech (EDSA) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $145K of Edesa Biotech stock for Q4 2019, down 4% quarter-over-quarter.
  • 2 funds opened new Edesa Biotech positions in Q4 2019 and 2 closed out, a net change of 0 holders.
  • The largest Edesa Biotech buyer in Q4 2019 was Renaissance Technologies, an estimated $47.1K added.
  • The largest Edesa Biotech seller in Q4 2019 was Morgan Stanley, an estimated $29.7K sold.

Based on aggregated 13F filings for Q4 2019.